Skip to main content

Table 5 Logistic regression analyses of bone mineral density and urinary parameters for symptomatic stones

From: Low bone mineral density is a potential risk factor for symptom onset and related with hypocitraturia in urolithiasis patients: a single-center retrospective cohort study

Factors

Univariate analysis

Multivariate analysis

OR (95% CI)

p value

OR (95% CI)

p value

T-score < − 2.5

1.57 (0.81–3.06)

0.18

2.59 (1.06–6.36)

0.037

Hypercalciuria

1.18 (0.53–2.61)

0.69

1.35 (0.49–3.71)

0.56

Hyperoxaluria

0.60 (0.37–0.97)

0.038

0.45 (0.24–0.83)

0.01

Hyperphosphaturia

0.99 (0.48–2.04)

0.97

1.20 (0.43–3.36)

0.72

Hypocitraturia

0.88 (0.57–1.36)

0.57

1.24 (0.72–2.13)

0.44

Female sex

0.78 (0.50–1.21)

0.27

0.82 (0.46–1.45)

0.49

age

0.99 (0.98–1.01)

0.25

1.00 (0.98–1.01)

0.63

body mass index

1.00 (0.95–1.05)

0.88

1.01 (0.96–1.07)

0.66

  1. Data were adjusted by age, body mass index, T-score, hypercalciuria, hyperoxaluria, hyperphosphaturia, hypocitraturia, and female gender
  2. Definitions of urine abnormalities: hypercalciuria ≥ 300 mg/day; hyperphosphaturia ≥ 3 g/day; hypernatriuria ≥ 5.8 g/day; hyperoxaluria ≥ 40 mg/day; hypocitraturia ≤ 320 mg/day